A study conducted by Israeli researchers in Haifa showed the short-term effectiveness and safety of micro doses of Medical Cannabis administered via a metered-dose inhaler (the Syqe Inhaler) in chronic pain patients, according to data published in Pain Reports journal.
“The administration of aerosolized cannabis through an inhaler may reduce long-term pain in patients with neuropathy and other chronic conditions,” researchers said. The daily stable dose investigators used for their patients was 1.5 mg of aerosolized delta-9-THC.
